Yixintang Pharmaceutical Group Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 3,428.551 million compared to CNY 3,086.924 million a year ago. Operating income was CNY 283.626 million compared to CNY 244.015 million a year ago. Net income was CNY 260.630 million compared to CNY 204.775 million a year ago. Basic earnings per share from continuing operations was CNY 0.4416 compared to CNY 0.3607 a year ago. Diluted earnings per share from continuing operations was CNY 0.44 compared to CNY 0.3568 a year ago.